# FusionX Ventures

> FusionX Ventures is a VC fund backing Health Care and Biotechnology. See 26 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Diego, United States
- Total investments: 26
- Last investment: Jun 2024
- Lead investor: 19%
- Fund size: $5.5M
- Last fund: Apr 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/fusionx-ventures/
- Website: http://www.fusionxventures.com/

FusionX Ventures is an early-stage investment fund focused on helping companies build the next generation of cloud-enabled Smart Machines. Its investment theme focuses on startups with products that fuse hardware, software, and cloud (IoT) that include a recurring revenue stream.

## Contacts

5 contacts available for FusionX Ventures. Shizune tracks 1 team members at FusionX Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fusionx-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 19% |
| Biotechnology | 3 | 12% |
| Food and Beverage | 3 | 12% |
| Coffee | 2 | 8% |
| Medical | 2 | 8% |

36 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 27% |
| Seed | 6 | 23% |
| Venture - Series Unknown | 3 | 12% |
| Pre-Seed | 2 | 8% |
| Series B | 2 | 8% |

9 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ken Hood | Managing Partner | 1 | https://shizune.co/investors/profile/ken-hood |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alida Biosciences | Alida Biosciences is a biotech company creating RNA analysis tools to improve human health. The company was founded in 2020 and is headquartered in San Diego, CA. | $7.5M | Series A | Jun 12, 2024 |  |
| NuMilk | NuMilk provides non-dairy, fresh milled almondmilk with the push of a button. |  | Venture - Series Unknown | Feb 05, 2024 |  |
| 3DEO | 3DEO’s patented metal additive manufacturing technology can make high-quality metal parts with drastically lower manufacturing costs, complex or traditionally impossible designs, immediate turnaround times. The company manufactures complex stainless steel parts for customers with a variety of applications from a wide range of industries. | $3.7M | Venture - Series Unknown | Jan 18, 2024 |  |
| Bellwether Coffee | Bellwether Coffee is making coffee roasting more accessible, and more sustainable for the environment and communities. With its controllable roaster available, Bellwether’s customers from large brands to small neighborhood cafes are in complete control of their coffee offerings using the electric, ventless, zero-emissions, award-winning BellwetherRoaster and intuitive roasting software. Bellwether Coffee is the recipient of the Best New Product award for 2019 by the Specialty Coffee Association.The company was founded in 2013 and is headquartered in Berkeley, California. | $1.1M | Venture - Series Unknown | Jun 15, 2023 |  |
| Intrepid Automation | Intrepid Automation, founded in 2017 is focused on solving big problems around next generation manufacturing platforms. |  | Series A | May 30, 2023 |  |
| NeuraLace Medical | Founded in 2016, NeuraLace is a technology company with a focus on medical innovations. The company is developing a non-invasive interface, bridging the gap between technology and neurology, to deliver sustainable chronic pain relief at scale. |  |  | Jan 20, 2023 |  |
| Alida Biosciences | Alida Biosciences is a biotech company creating RNA analysis tools to improve human health. The company was founded in 2020 and is headquartered in San Diego, CA. | $4M | Seed | May 11, 2022 |  |
| 1859 | 1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics. The company was founded in 2019 and is headquartered in San Diego, California. | $40M | Series A | Feb 07, 2022 |  |
| NanoCellect Biomedical | NanoCellect Biomedical, Inc. aims to make flow cytometry and cell sorting technology more affordable and accessible for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine.A critical element for biomedical research is the ability for scientists to analyze and isolate cellsusing flow cytometers. Scientists use flow cytometers to obtain a fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest.NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. | $20M | Series D | Aug 13, 2021 |  |
| Alida Biosciences | Alida Biosciences is a biotech company creating RNA analysis tools to improve human health. The company was founded in 2020 and is headquartered in San Diego, CA. | $510K | Pre-Seed | Jul 02, 2021 |  |

10 of 26 investments shown.

## Co-investors
- [Vertical Venture Partners](https://shizune.co/investors/profile/vertical-venture-partners) — VC Fund, 7 deals together
- [Illumina Ventures](https://shizune.co/investors/profile/illumina-ventures) — VC Fund, 3 deals together
- [Tandem Capital](https://shizune.co/investors/profile/tandem-capital-2) — VC Fund, 3 deals together
- [Genoa Ventures](https://shizune.co/investors/profile/5-prime-ventures) — VC Fund, 2 deals together
- [Anzu Partners](https://shizune.co/investors/profile/anzu-partner) — VC Fund, 2 deals together
- [Oregon Venture Fund](https://shizune.co/investors/profile/oregon-angel-fund) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does FusionX Ventures invest in?

FusionX Ventures invests primarily in Health Care, Biotechnology and Food and Beverage startups, most often at Series A and Seed stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact FusionX Ventures?

Public channels for FusionX Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at FusionX Ventures?

The team at FusionX Ventures includes Ken Hood (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co